(3-(1-((3-(cyclohexylmethyl)hydroxyphosphinyl)-2-hydroxypropyl)amino)ethyl)benzoic acid has been researched along with Gait Disorders, Animal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baizer, JS; Broussard, DM; Heskin-Sweezie, R; Titley, HK | 1 |
1 other study(ies) available for (3-(1-((3-(cyclohexylmethyl)hydroxyphosphinyl)-2-hydroxypropyl)amino)ethyl)benzoic acid and Gait Disorders, Animal
Article | Year |
---|---|
Type B GABA receptors contribute to the restoration of balance during vestibular compensation in mice.
Topics: Adaptation, Physiological; Animals; Ataxia; Baclofen; Benzoates; GABA-B Receptor Agonists; GABA-B Receptor Antagonists; gamma-Aminobutyric Acid; Lameness, Animal; Male; Mice; Mice, Inbred C57BL; Phenols; Phosphinic Acids; Postural Balance; Receptors, GABA-B; Recovery of Function; Reflex; Vestibular Nucleus, Lateral; Vestibule, Labyrinth | 2010 |